COMMUNIQUÉS West-GlobeNewswire

QHSLab Announces Major Research and Development Milestones for 2024: Doubling Assessment Completion and Advancing Digital Medicine Innovation

17/09/2024 - 15:00

WEST PALM BEACH, FL, Sept. 17, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based [...]

Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases

17/09/2024 - 15:00

ATH-1105 is an orally delivered, positive modulator of the neurotrophic HGF system that is currently in a Phase 1 clinical trial with completion expected by year end 2024 and commencement of dosing of ALS patients [...]

Foxo Technologies, Inc., Completes the Acquisition of Revenue Generating Operations From Rennova Health, Inc.

17/09/2024 - 15:00

Strategic Acquisitions Expected to Generate Over $20M in Annual Revenue, Positioning FOXO for Accelerated Growth MINNEAPOLIS, MN, Sept. 17, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “ [...]

Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection

17/09/2024 - 15:00

Assessment by specialist AI team from “PersonalAIze” Highlights the Strength, Potential, and Visionary Talent Behind the Innovative Software as a Service (SaaS) Platform AMSTERDAM, Sept. 17, 2024 (GLOBE NEWSWIRE) -- ( [...]

Merus Announces Abstract Accepted for Presentation at the ESMO Asia Congress 2024

17/09/2024 - 15:00

Petosemtamab in 2L+ HNSCC interim clinical data selected for rapid oral presentation UTRECHT, The Netherlands and CAMBRIDGE, Mass., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, [...]

Philips announces FDA approval for enhanced LumiGuide guidewire and marks the 1000th patient treated with its breakthrough 3D device guidance technology

17/09/2024 - 14:56

Enhanced longer version of Philips LumiGuide Navigation Wire enables US clinicians to visualize a broader range of catheters Internationally recognized vascular surgeon Carlos Timaran, MD, was the first to use the new [...]

KFSHRC at the forefront of precision medicine and genomic therapies in Saudi Arabia and the region

17/09/2024 - 14:48

RIYADH, Saudi Arabia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is integrating genomic profiling and pharmacogenomics into clinical practice. These enhancements [...]

Elicio Therapeutics Reports Inducement Grants

17/09/2024 - 14:31

BOSTON, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the [...]

Employer Direct Healthcare Becomes Lantern; Adds New Infusion Offering, and Hires New Clinical Leadership

17/09/2024 - 14:30

Former Teladoc, CVS Health, and Hinge Health Executives Join Company’s Clinical Team as Specialty Care Platform Expands to Support People through Surgery, Cancer, and Infusion Therapy DALLAS, Sept. 17, 2024 (GLOBE [...]

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

17/09/2024 - 14:30

Completion of enrollment expected in Q4 with FDA submission for commercialization anticipated by the end of 2024 BRAINTREE, Mass., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of [...]

INmune Bio Announces Results of Additional Blinded Interim Analysis of Phase 2 Alzheimer's Disease Trial Demonstrating Correlation between EMACC and CDR-SB Endpoints

17/09/2024 - 14:30

BOCA RATON, Fla., Sept. 17, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage immunology and inflammation company, today announced that results of additional analysis of blinded [...]

Alkeus Pharmaceuticals Announces Results from the SAGA Study of Oral Gildeuretinol in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration

17/09/2024 - 14:30

Oral gildeuretinol demonstrated a clinically meaningful reduction in the geographic atrophy (GA) lesion growth rate at 24 months, supporting further clinical development. Gildeuretinol showed a statistically significant [...]

Canadian Scientist Franco Cavaleri Expands Biomedical Research into Cancer Studies through International Collaboration with Indian University

17/09/2024 - 14:25

VANCOUVER, British Columbia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Acclaimed biomedical researcher and bestselling author Franco Cavaleri, known for his contributions to natural medicine and health innovation, has entered [...]

STRATA Skin Sciences to Present at the iAccess Alpha - Buyside Best Ideas Fall Conference 2024

17/09/2024 - 14:15

HORSHAM, Pa., Sept. 17, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]

Noom Appoints Rachel Mahoney as Chief Brand Officer

17/09/2024 - 14:02

Executive Joins Noom Following Launch of New Product Pairing Powerful Behavior Change Program with Powerful Medications for Lasting Weight Loss NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Noom , the leading digital [...]

Spectral AI Outlines U.S. Regulatory Pathway for DeepView® System for Burn Indication

17/09/2024 - 14:00

DALLAS, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate [...]

AnewHealth Appoints Chief Growth Officer and Executive Vice President of Strategic Partnerships

17/09/2024 - 14:00

The addition of key members to its leadership team will support AnewHealth in growing strategically as it continues to reinvent pharmacy care for people with complex, chronic medical needs CLEVELAND, OH and MOORESTOWN, [...]

Inovalon’s Payer Cloud Ranked #1 in 2024 By Black Book Research

17/09/2024 - 14:00

Health Insurance Organizations Nationwide Rank Inovalon’s Payer Cloud as Top Payer Technology and Data Platform for Fourth Consecutive Year BOWIE, Md., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Inovalon , a leading provider of [...]

Endomimetics™ Awarded $2.8 Million Phase II SBIR Grant to Develop and Evaluate the Potential of Bionanomatrix™ to Improve Performance and Patient Outcomes in the Treatment of Brain Aneurysms

17/09/2024 - 14:00

Funding will support research evaluating application of Bionanomatrix to flow diverters to accelerate healing after implantation BIRMINGHAM, Ala., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Endomimetics, the developer of [...]